(Total Views: 685)
Posted On: 12/22/2020 12:16:59 PM
Post# of 151008
EINDs reinstated is a positive development IMO.
Does everyone agree? Seems FDA would not do unless they think LL helps.
Dec 22 (Reuters) - Cytodyn Inc:
* FDA RESUMES EIND APPROVAL FOR SEVERE-TO-CRITICAL COVID-19 PATIENTS USE OF VYROLOGIX™ (LERONLIMAB) FOLLOWING FULL ENROLLMENT IN CYTODYN’S PHASE 3 TRIAL
* CYTODYN INC - FDA'S DECISION WILL ENABLE CYTODYN TO RESPOND TO ONGOING REQUESTS FOR LERONLIMAB UNTIL PHASE 3 TRIAL DATA IS UNBLINDED Source text for Eikon: Further company coverage:
Does everyone agree? Seems FDA would not do unless they think LL helps.
Dec 22 (Reuters) - Cytodyn Inc:
* FDA RESUMES EIND APPROVAL FOR SEVERE-TO-CRITICAL COVID-19 PATIENTS USE OF VYROLOGIX™ (LERONLIMAB) FOLLOWING FULL ENROLLMENT IN CYTODYN’S PHASE 3 TRIAL
* CYTODYN INC - FDA'S DECISION WILL ENABLE CYTODYN TO RESPOND TO ONGOING REQUESTS FOR LERONLIMAB UNTIL PHASE 3 TRIAL DATA IS UNBLINDED Source text for Eikon: Further company coverage:
(4)
(0)Scroll down for more posts ▼
